Efficacy and safety of infliximab in treating patients with ulcerative colitis: Experiences from a single medical center in southern China

This study aimed to evaluate the efficacy including the patients' response rates to infliximab (IFX) therapy, relapse rates after IFX-induced clinical remission, and the safety of IFX in Chinese patients with ulcerative colitis (UC) from a single center in southern China and to identify the risk factors associated with disease relapse.Medical records of Chinese UC patients who were diagnosed and received at least two infusions of IFX at Nanfang...